BioTrove's First-Half '08 Revenues Rise 64 Percent in Advance of IPO | GenomeWeb
NEW YORK (GenomeWeb News) – BioTrove’s revenues for the first half of 2008 increased 64 percent over the first half of 2007 due in part to strong sales for its RapidFire sample prep system for mass spectrometry applications, according to an amended IPO registration statement filed with the US Securities and Exchange Commission last week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.